APA (7th ed.) Citation

Ahmed, A. A. S., Alkheder, A., Ali, M. A., Abdelraouf, M. R., Ashour, T. A., Salamah, H. M., . . . Hakim, D. Efficacy and safety of tafolecimab a new PCSK9 inhibitor in patients with hyperlipidemia: A systematic review and meta-analysis of randomized controlled trials. SpringerOpen.

Chicago Style (17th ed.) Citation

Ahmed, Ali Ashraf Salah, Ahmad Alkheder, Mohamed Ahmed Ali, Mohamed R. Abdelraouf, Toka Ahmed Ashour, Hazem Mohamed Salamah, Abdelrahman Mahmoud, and Diaa Hakim. Efficacy and Safety of Tafolecimab a New PCSK9 Inhibitor in Patients with Hyperlipidemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. SpringerOpen.

MLA (9th ed.) Citation

Ahmed, Ali Ashraf Salah, et al. Efficacy and Safety of Tafolecimab a New PCSK9 Inhibitor in Patients with Hyperlipidemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. SpringerOpen.